{
    "Trade/Device Name(s)": [
        "ABX PENTRA Urea CP",
        "ABX PENTRA Urine Control L/H"
    ],
    "Submitter Information": "Horiba ABX",
    "510(k) Number": "K070146",
    "Predicate Device Reference 510(k) Number(s)": [
        "K971477",
        "K070249"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CDQ",
        "JJY"
    ],
    "Summary Letter Date": "September 24, 2007",
    "Summary Letter Received Date": "September 27, 2007",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1770",
        "21CFR862.1660"
    ],
    "Regulation Name(s)": [
        "Urea Nitrogen Test System",
        "Quality control material (assayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Urea",
        "Blood Urea Nitrogen"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma",
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ABX PENTRA 400"
    ],
    "Method(s)/Technology(ies)": [
        "Enzymatic UV test",
        "Urease and glutamate dehydrogenase"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Assay",
        "Control",
        "Calibrator"
    ],
    "Document Summary": "FDA 510(k) summary for ABX PENTRA Urea CP assay and ABX PENTRA Urine Control L/H for measuring urea/urea nitrogen using the ABX PENTRA 400 analyzer.",
    "Indications for Use Summary": "Intended for quantitative in vitro diagnostic determination of urea/urea nitrogen in human serum, plasma, and urine for diagnosis and treatment of certain renal and metabolic diseases; urine controls for monitoring accuracy and precision.",
    "fda_folder": "Clinical Chemistry"
}